Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)
ACAD Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
132.60%
Analyst Rating:
BUY
Analyst Forecast (1yr):
53.70%
ACAD Stock Analysis
ACAD
PE Ratio:
9.7
ACAD
PEG Ratio:
0.1
ACAD
Forward EPS Growth (12 month):
115.40%
ACAD
PS Ratio:
3.4
ACAD
PSG Ratio:
0.3
ACAD
Forward Revenue Growth (12 month):
11.80%
ACAD Articles
No data was found